−1.36USD
−37.34 MUSD
55.88 M
About SELLAS Life Sciences Group, Inc.
Sector
CEO
Angelos M. Stergiou
Headquarters
New York
Website
Employees (FY)
16
Founded
2006
ISIN
US81642T2096
FIGI
BBG000VC77H7
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SLS is 1.52 USD — it has increased by 7.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange SELLAS Life Sciences Group, Inc. stocks are traded under the ticker SLS.
SELLAS Life Sciences Group, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
SLS stock is 9.29% volatile and has beta coefficient of 1.65. Check out the list of the most volatile stocks — is SELLAS Life Sciences Group, Inc. there?
One year price forecast for SELLAS Life Sciences Group, Inc. has a max estimate of 7.50 USD and a min estimate of 4.00 USD.
SLS earnings for the last quarter are −0.33 USD whereas the estimation was 0.02 USD which accounts for −1.99 K% surprise. Estimated earnings for the next quarter are 0.09 USD. See more details about SELLAS Life Sciences Group, Inc. earnings.
SELLAS Life Sciences Group, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 13.00 M USD. In the next quarter revenue is expected to reach 13.00 M USD.
Yes, you can track SELLAS Life Sciences Group, Inc. financials in yearly and quarterly reports right on TradingView.
SLS stock has risen by 9.35% compared to the previous week, the month change is a 35.71% rise, over the last year SELLAS Life Sciences Group, Inc. has showed a 5.00% decrease.
SLS net income for the last quarter is −8.14 M USD, while the quarter before that showed −9.27 M USD of net income which accounts for 12.20% change. Track more SELLAS Life Sciences Group, Inc. financial stats to get the full picture.
Today SELLAS Life Sciences Group, Inc. has the market capitalization of 79.34 M, it has increased by 22.46% over the last week.
No, SLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SELLAS Life Sciences Group, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 16.00 employees. See our rating of the largest employees — is SELLAS Life Sciences Group, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SELLAS Life Sciences Group, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SELLAS Life Sciences Group, Inc. stock shows the sell signal. See more of SELLAS Life Sciences Group, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SELLAS Life Sciences Group, Inc. future price: according to them, SLS price has a max estimate of 7.50 USD and a min estimate of 4.00 USD. Read a more detailed SELLAS Life Sciences Group, Inc. forecast: see what analysts think of SELLAS Life Sciences Group, Inc. and suggest that you do with its stocks.